Variant report
Variant | esv3584889 |
---|---|
Chromosome Location | chr8:52188402-52197148 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144095518 | chr8:52188451-52188452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527734682 | chr8:52188468-52188469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7818297 | chr8:52188501-52188502 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs190232638 | chr8:52188535-52188536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532068319 | chr8:52188536-52188537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537735648 | chr8:52188549-52188550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34668355 | chr8:52188605-52188606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28486051 | chr8:52188627-52188628 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs535661074 | chr8:52188630-52188631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554363147 | chr8:52188658-52188659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558533780 | chr8:52188695-52188696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539510578 | chr8:52188717-52188718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557801883 | chr8:52188738-52188739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575931550 | chr8:52188787-52188788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543727616 | chr8:52188789-52188790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142965171 | chr8:52188796-52188797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73573901 | chr8:52188817-52188818 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs540830230 | chr8:52188834-52188835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559094863 | chr8:52188836-52188837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181486758 | chr8:52188838-52188839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574077452 | chr8:52188860-52188861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527797359 | chr8:52188911-52188912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113772300 | chr8:52188944-52188945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564533987 | chr8:52188969-52188970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531608481 | chr8:52189050-52189051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187015237 | chr8:52189068-52189069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562249924 | chr8:52189102-52189103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553510268 | chr8:52189108-52189109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533955633 | chr8:52189130-52189131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377649324 | chr8:52189163-52189164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529562006 | chr8:52189165-52189166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573252774 | chr8:52189182-52189183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566240193 | chr8:52189185-52189186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147493116 | chr8:52189264-52189265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553836405 | chr8:52189292-52189293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540888876 | chr8:52189359-52189360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551477516 | chr8:52189384-52189385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569680142 | chr8:52189385-52189386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190905982 | chr8:52189437-52189438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs16915954 | chr8:52189472-52189473 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs573874541 | chr8:52189501-52189502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534571409 | chr8:52189535-52189536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559031370 | chr8:52189555-52189556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552785458 | chr8:52189559-52189560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6991317 | chr8:52189596-52189597 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs139957796 | chr8:52189601-52189602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58535627 | chr8:52189605-52189606 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs142946230 | chr8:52189606-52189607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543452238 | chr8:52189621-52189622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541908918 | chr8:52189667-52189668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52180400-52189400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr8:52184200-52197800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:52185600-52188600 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr8:52188000-52191200 | Enhancers | Fetal Brain Male | brain |
5 | chr8:52188200-52191200 | Enhancers | Brain Germinal Matrix | brain |
6 | chr8:52188800-52191200 | Enhancers | Fetal Brain Female | brain |
7 | chr8:52189200-52190800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr8:52189400-52189600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr8:52189400-52190200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr8:52189400-52190400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr8:52189400-52190400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr8:52189600-52189800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr8:52190200-52193800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr8:52190400-52191400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr8:52191600-52191800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr8:52193800-52194000 | Enhancers | Pancreas | Pancrea |
17 | chr8:52193800-52194400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr8:52193800-52194400 | Enhancers | Fetal Lung | lung |